Compare ETFs and analyze holdings overlap
Search and add ETFs. Minimum 2 for comparison.
| ETF | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception |
|---|---|---|---|---|---|---|---|---|---|
| TDOC | 1.40% | 8.52% | 2.10% | — | 14.26% | 6.89% | 4.96% | — | 6.98% (Apr 2021) |
Last six full-calendar years
| ETF | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| TDOC | — | — | — | — | — | — |
TWR = Time-Weighted Return (measures fund performance). MWRR = Money-Weighted Return (measures your personal return including contribution timing). Past performance does not guarantee future results.
Latest reported top holdings for each ETF
| # | Holding | Weight |
|---|---|---|
| 1 | UnitedHealth Group Inc | 2.64% |
| 2 | Novo Nordisk A/S | 2.48% |
| 3 | Eli Lilly and Co | 2.35% |
| 4 | Abbvie Inc | 2.31% |
| 5 | Thermo Fisher Scientific Inc | 2.24% |
| 6 | Bristol-Myers Squibb Co | 2.14% |
| 7 | Roche Holding AG - Partcptn | 2.13% |
| 8 | Amgen Inc | 2.11% |
| 9 | Vertex Pharmaceuticals Inc | 2.09% |
| 10 | Johnson & Johnson | 2.07% |
Our in-depth Canadian investing course covers ETFs, TFSAs, RRSPs, and building a portfolio you can stick with.